You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PXT3003

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Charcot-Marie-Tooth Type 1A Trial in China (PXT3003, PXT3003 )

Recruiting
  • Charcot-Marie-Tooth Type 1A
  • PXT3003
  • PXT3003 placebo
  • Beijing, China
  • +24 more
Feb 15, 2022

Charcot-Marie-Tooth Disease Trial in Worldwide ((RS)-baclofen, naltrexone HCl and D-sorbitol, Placebo)

Active, not recruiting
  • Charcot-Marie-Tooth Disease
  • (RS)-baclofen, naltrexone hydrochloride and D-sorbitol
  • Placebo
  • Los Angeles, California
  • +49 more
May 3, 2022

Charcot-Marie-Tooth Disease, Type IA Trial in Worldwide (PXT3003)

Active, not recruiting
  • Charcot-Marie-Tooth Disease, Type IA
  • PXT3003
  • Los Angeles, California
  • +22 more
Mar 9, 2021

Charcot-Marie-Tooth Disease, Hereditary Neuropathy With Liability to Pressure Palsies, Genetic Disorders Trial in France

Completed
Has Results
  • Charcot-Marie-Tooth Disease
  • +2 more
  • PXT3003 Low dose
  • +3 more
  • Lille, France
  • +5 more
Oct 19, 2017